Nelson Vergel
Founder, ExcelMale.com
A San Diego-based startup called Pathway Genomics released a blood test today that it says can detect mutations associated with multiple cancers. If true, the $699 test would be a big deal for medicine because it could be used to catch cancer before a person shows symptoms. But Pathway Genomics doesn’t have data that shows that the test actually works.
Pathway Genomics hasn’t finished the type of study that could be used to validate their claims — a fact the company acknowledges — so the company itself doesn’t know if its claims are true. And the FDA hasn’t reviewed the product, either. But that hasn't stopped it from marketing the test as a "cancer stethoscope."
http://www.theverge.com/2015/9/10/9...cs-cancer-blood-test-cancerintercept-evidence
Pathway Genomics hasn’t finished the type of study that could be used to validate their claims — a fact the company acknowledges — so the company itself doesn’t know if its claims are true. And the FDA hasn’t reviewed the product, either. But that hasn't stopped it from marketing the test as a "cancer stethoscope."
http://www.theverge.com/2015/9/10/9...cs-cancer-blood-test-cancerintercept-evidence
